These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 26780424)
1. Current advances in therapies for calcium pyrophosphate crystal arthritis. Sivera F; Andrés M; Pascual E Curr Opin Rheumatol; 2016 Mar; 28(2):140-4. PubMed ID: 26780424 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease? Pascual E; Andrés M; Sivera F Arthritis Res Ther; 2015 Apr; 17(1):89. PubMed ID: 25885915 [TBL] [Abstract][Full Text] [Related]
3. Therapy for CPPD: Options and Evidence. Andrés M; Sivera F; Pascual E Curr Rheumatol Rep; 2018 Apr; 20(6):31. PubMed ID: 29675606 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis. Moltó A; Ea HK; Richette P; Bardin T; Lioté F Joint Bone Spine; 2012 Dec; 79(6):621-3. PubMed ID: 22658375 [TBL] [Abstract][Full Text] [Related]
15. Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis. Andres M; Sivera F; Pascual E J Clin Rheumatol; 2012 Aug; 18(5):234-6. PubMed ID: 22832286 [TBL] [Abstract][Full Text] [Related]